Search - tctmd.com

Displaying 101 - 112 of 112

Sort: Relevancy | Date

Case 2: Patient with Stable Class 3 Angina, Triple-Vessel CAD, and Intermediate Syntax and STS Scores(2)

Presentation TCT 2012

Case 2: Patient with Stable Class 3 Angina, Triple-Vessel CAD, and Intermediate Syntax and STS Scores(2)

Presenter: Megan Coylewright

October 26, 2012

Case 2: Patient with Stable Class 3 Angina, Triple-Vessel CAD, and Intermediate Syntax and STS Scores

Presentation TCT 2012

Case 2: Patient with Stable Class 3 Angina, Triple-Vessel CAD, and Intermediate Syntax and STS Scores

Presenter: Megan Coylewright

October 26, 2012

News Conference News TCT 2012

PEACE: Data Demonstrate Benefits of Plaque Identification in High-Risk Patients

October 24, 2012

News Conference News TCT 2012

Paradigm Shift from Ischemia to Vulnerable Plaque Needed to Prevent Sudden Coronary Death

October 24, 2012

News Conference News TCT 2012

FAME 2: FFR-Guided PCI Cost Effective vs. Medical Therapy

October 24, 2012

News Conference News TCT 2012

PARADOX: Smoking Enhances Effect of Clopidogrel, Prasugrel Unaffected by Smoking Status

October 23, 2012

Do Patient and Stent Platform Specific Variables Matter (e.g. ACS vs. Stable CAD, First vs. Second Generation DES)?

Presentation TCT 2012

Do Patient and Stent Platform Specific Variables Matter (e.g. ACS vs. Stable CAD, First vs. Second Generation DES)?

Presenter: Elvin Kedhi

October 22, 2012

Calcified Lesions: New Insights in Stable CAD and ACS from Large-Scale Clinical Trials

Presentation TCT 2012

Calcified Lesions: New Insights in Stable CAD and ACS from Large-Scale Clinical Trials

Presenter: Philippe Genereux

October 22, 2012

News Conference News

TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 Year

November 28, 2011

News Conference News

RAPID GENE: Validation of Point-of-Care Genetic Testing

November 09, 2011

News Conference News

ADAPT-DES: Risk of Early Stent Thrombosis in DES Predicted by Platelet Inhibition

November 09, 2011

News Conference News

EES Compared Favorably with SES In Two Pivotal Trials

November 08, 2011

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.